Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
February 2, 2023 Off

Mednow Launches New Virtual Diabetes Management Program in Partnership With Dexcom

By BusinessWire

Virtual pharmacy care program provides convenient access to Dexcom G6 rtCGM supplies and diabetes management support services TORONTO–(BUSINESS WIRE)–Mednow Inc.…

February 2, 2023 Off

Verastem Oncology Outlines Key 2023 Strategic Priorities and Upcoming Catalysts for Advancing Avutometinib as a Backbone of Therapy for RAS Pathway-Driven Cancers

By BusinessWire

Avutometinib + Defactinib Combination Advancing in Recurrent Low-Grade Serous Ovarian Cancer (LGSOC) Based on Positive Data from Planned Interim Analysis…

February 2, 2023 Off

Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2022

By BusinessWire

Reports Fourth Quarter Revenues of $11.4 Billion; Full-Year Revenues of $46.2 Billion Fourth Quarter Revenues from In-Line Products and New…

February 2, 2023 Off

Harrow Announces Permanent, Product-Specific J-Code (J2403) for IHEEZO™ (Chloroprocaine Hydrochloride Ophthalmic Gel) 3% for Ocular Surface Anesthesia Effective April 1, 2023

By BusinessWire

NASHVILLE, Tenn.–(BUSINESS WIRE)–$HROW–Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced that the Centers for Medicare & Medicaid…

February 2, 2023 Off

Karuna Therapeutics Announces Exclusive Global License Agreement for Goldfinch Bio’s Investigational TRPC4/5 Product Candidates

By BusinessWire

Karuna to obtain exclusive global license to develop, manufacture, and commercialize multiple TRPC4/5 candidates, including lead clinical-stage candidate GFB-887 Goldfinch…

February 2, 2023 Off

Merck Announces Fourth-Quarter and Full-Year 2022 Financial Results

By BusinessWire

Fourth-Quarter and Full-Year 2022 Results Reflect Sustained Strong Revenue Growth Fourth-Quarter 2022 Worldwide Sales Were $13.8 Billion, an Increase of…

February 2, 2023 Off

Worldwide Recombinant Cell Culture Supplements Industry to 2027 – Featuring Abcam, Corning, BBI Solutions OEM and FUJIFILM Irvine Scientific Among Others – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Recombinant Cell Culture Supplements Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Product,…

February 2, 2023 Off

Sensorion Will Present Two Posters at the Association for Research in Otolaryngology ARO 46th Annual MidWinter Meeting

By BusinessWire

MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel…

February 2, 2023 Off

Takeda Reinforces Long-term Growth Through Pipeline Advancement and Two Targeted Acquisitions; Delivers Another Strong Quarter in FY2022 Q3

By BusinessWire

Announced Agreement With Nimbus Therapeutics in December to Acquire a Potential Best-in-Class TYK2 Inhibitor, and with HUTCHMED in January to…

February 2, 2023 Off

Vaxxinity Announces Board Appointments and Establishes New Headquarters in Florida

By GlobeNewswire

Appointment of new directors bring diversity, balance and relevant industry expertise to Vaxxinity Establishment of Frontier Exploration Laboratories (“VaxxLabs”) in…

Posts navigation

Previous 1 2 3 4 … 4,604 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Sesen Bio Files Investor Presentation in Connection with Pending Carisma Therapeutics Merger

February 3, 2023 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off
Proudly powered by WordPress | Theme: Envo Magazine